• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels.

作者信息

Souza Dos Santos R A, Passaglio K T, Pesquero J B, Bader M, Simões E Silva A C

机构信息

Laboratório de Hipertensão, Instituto de Ciências Biológicas, Departamento de Pediatria, Fac. Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

出版信息

Hypertension. 2001 Sep;38(3 Pt 2):660-4. doi: 10.1161/01.hyp.38.3.660.

DOI:10.1161/01.hyp.38.3.660
PMID:11566951
Abstract

The heptapeptide angiotensin (Ang)-(1-7) is currently considered one of the biologically active end products of the renin-angiotensin system. The formation of Ang-(1-7) by pathways independent of Ang II generation, the selectivity of its actions, and its peculiar property of exhibiting effects that are partially opposite of those of the parent compound, Ang II, confer a unique biochemical and functional profile to this peptide. In this article, we will review novel aspects of the biological actions of Ang-(1-7), dealing with its interaction with Ang II and kinins, especially in the kidney and blood vessels.

摘要

相似文献

1
Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels.
Hypertension. 2001 Sep;38(3 Pt 2):660-4. doi: 10.1161/01.hyp.38.3.660.
2
Angiotensin-(1-7): an update.血管紧张素-(1-7):最新进展
Regul Pept. 2000 Jul 28;91(1-3):45-62. doi: 10.1016/s0167-0115(00)00138-5.
3
Differential actions of angiotensin-(1-7) in the kidney.血管紧张素 -(1 - 7)在肾脏中的不同作用。
Kidney Int Suppl. 1998 Dec;68:S3-6. doi: 10.1038/sj.ki.4490555.
4
New insights into actions of the renin-angiotensin system in the kidney: concentrating on the Ang II receptors and the newly described Ang-(1-7) and its receptor.肾素 - 血管紧张素系统在肾脏中作用的新见解:聚焦于血管紧张素II受体以及新描述的血管紧张素 -(1 - 7)及其受体。
Semin Nephrol. 2001 Nov;21(6):535-43. doi: 10.1053/snep.2001.26792.
5
Antihypertensive effects of angiotensin-(1-7).血管紧张素-(1-7)的降压作用
Braz J Med Biol Res. 1998 Sep;31(9):1205-12. doi: 10.1590/s0100-879x1998000900014.
6
Cardiovascular actions of angiotensin-(1-7).血管紧张素-(1-7)的心血管作用。
Braz J Med Biol Res. 2005 Apr;38(4):499-507. doi: 10.1590/s0100-879x2005000400003. Epub 2005 Apr 13.
7
Pathways of angiotensin formation and function in the brain.大脑中血管紧张素的形成途径及其功能
Hypertension. 1990 Feb;15(2 Suppl):I13-9. doi: 10.1161/01.hyp.15.2_suppl.i13.
8
Central and peripheral actions of angiotensin-(1-7).血管紧张素-(1-7)的中枢和外周作用。
Braz J Med Biol Res. 1994 Apr;27(4):1033-47.
9
Angiotensin-(1-7): an active member of the renin-angiotensin system.血管紧张素-(1-7):肾素-血管紧张素系统的一个活性成员。
J Physiol Pharmacol. 2002 Dec;53(4 Pt 1):533-40.
10
Angiotensin-(1-7): blood, heart, and blood vessels.血管紧张素 -(1 - 7):血液、心脏与血管。
Curr Med Chem Cardiovasc Hematol Agents. 2005 Oct;3(4):383-91. doi: 10.2174/156801605774322373.

引用本文的文献

1
Serine proteases and protease-activated receptors signaling in the kidney.肾脏中的丝氨酸蛋白酶与蛋白酶激活受体信号传导
Am J Physiol Cell Physiol. 2025 Jul 1;329(1):C107-C117. doi: 10.1152/ajpcell.00143.2025. Epub 2025 Apr 17.
2
Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial.在一项随机对照试验中,新冠病毒病患者停用肾素-血管紧张素系统抑制剂并未改变全身血管紧张素转换酶2水平。
iScience. 2023 Oct 5;26(11):108146. doi: 10.1016/j.isci.2023.108146. eCollection 2023 Nov 17.
3
Renin-Angiotensin System Components and Arachidonic Acid Metabolites as Biomarkers of COVID-19.
肾素-血管紧张素系统成分及花生四烯酸代谢产物作为新型冠状病毒肺炎的生物标志物
Biomedicines. 2023 Jul 27;11(8):2118. doi: 10.3390/biomedicines11082118.
4
Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.Mas 受体:缺血性心血管疾病治疗的潜在策略。
Cell Cycle. 2023 Jul;22(13):1654-1674. doi: 10.1080/15384101.2023.2228089. Epub 2023 Jun 26.
5
The des-Arg-bradykinin/B1R axis: Hepatic damage in COVID-19.去精氨酸缓激肽/B1R轴:新冠病毒感染中的肝损伤
Front Physiol. 2022 Dec 19;13:1080837. doi: 10.3389/fphys.2022.1080837. eCollection 2022.
6
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic.高血压的代偿性肾素-血管紧张素系统:COVID-19 大流行时代的回顾与更新。
Biochem Pharmacol. 2023 Feb;208:115370. doi: 10.1016/j.bcp.2022.115370. Epub 2022 Dec 5.
7
COVID-19 and renin angiotensin aldosterone system: Pathogenesis and therapy.新型冠状病毒肺炎与肾素血管紧张素醛固酮系统:发病机制与治疗
Health Sci Rep. 2021 Nov 17;4(4):e440. doi: 10.1002/hsr2.440. eCollection 2021 Dec.
8
Angiotensin-(1-7)-A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic.血管紧张素-(1-7):急性肾损伤的潜在治疗方法——从新冠疫情中获得的见解
J Clin Med. 2021 Mar 13;10(6):1200. doi: 10.3390/jcm10061200.
9
Prolylcarboxypeptidase Mitigates Myocardial Ischemia/Reperfusion Injury by Stabilizing Mitophagy.脯氨酰羧肽酶通过稳定线粒体自噬减轻心肌缺血/再灌注损伤。
Front Cell Dev Biol. 2020 Oct 22;8:584933. doi: 10.3389/fcell.2020.584933. eCollection 2020.
10
Why Children are Less Likely to Contract COVID-19 Infection than Adults?为什么儿童感染新冠病毒的可能性比成人小?
Int J Prev Med. 2020 Jun 19;11:74. doi: 10.4103/ijpvm.IJPVM_199_20. eCollection 2020.